Skip to main content
TipRanks
Go Ultimate75% OFF

Alejandro Galindo Insider Profile

11 Followers

Alejandro Galindo, EVP Endocrine Business Unit at MannKind, holds 777.08K shares in MannKind (Ticker: MNKD). Most recently, Alejandro Galindo Sold 4,615 shares of MannKind on Aug 23, 2022 for an estimated value of $17.77K.

Alejandro Galindo's Trading History

MNKD
MannKind
Aug 23, 2022EVP Endocrine Business UnitInformative Sell17.77K$3.21M
MNKD
Insider Shares: 777.08K (0.31%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 23, 2022Informative Sell$17.77K4,615$3.84-19.30%
Aug 01, 2022Uninformative Buy$14.65K5,000$2.93―
May 20, 2022Uninformative Sell$15.28K4,789$3.19―
May 12, 2022Uninformative Buy$0.00200,000$0.00―
Mar 01, 2022Informative Buy$100.00K36,900$2.71+41.00%

You May Also Like

Alejandro Galindo insider profile FAQ

What is the percentage of profitable transactions made by Alejandro Galindo?
The percentage of profitable transactions made by Alejandro Galindo is 50%.
What is the average return per transaction made by Alejandro Galindo?
The average return per transaction made by Alejandro Galindo is 10.80%.
What stocks does Alejandro Galindo hold?
Alejandro Galindo holds: MNKD stocks.
What was Alejandro Galindo’s latest transaction?
Alejandro Galindo’s latest transaction was an Informative Sell of $17.77K.
What was Alejandro Galindo's most profitable transaction?
Alejandro Galindo’s most profitable transaction was an Informative Buy of MNKD stock on March 1, 2022. The return on the trade was 41.00%.
What is Alejandro Galindo's role in MannKind?
Alejandro Galindo's role in MannKind is EVP Endocrine Business Unit.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.